Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Impaired Liver Function and Healthy Participants Matched for Age-, Gender-, and Weight
Clinical trial NCT04366622 · COMPLETED
Trial details
- NCT number
- NCT04366622
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-14
- Primary completion
- 2011-04-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.